Lobbying

The US Cannabis Roundtable's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $220K. Its first report covers Q1 2024; the issues it reports most are Banking and Financial Institutions/Investments/Securities.

The US Cannabis Roundtable

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$220K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

The US Cannabis Roundtable lobbying by quarter
The US Cannabis Roundtable lobbying by quarter
QuarterAmountReports
Q1 2024$30K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$60K1
Q1 2026$80K1
Q2 2026$80K1
Q3 2026$00

By issue

  • Banking$225K · 10 reports
  • Financial institutions and securities$140K · 6 reports
  • Health issues$85K · 4 reports
  • Budget and appropriations$60K · 3 reports
  • Agriculture$40K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports
  • Treasury, Dept of2 reports

Firms it paid

Firm
Holland & Knight$550K10 quarters

Former officials lobbying for it

Former position
TODD WOOTENLA, Counsel, Sen. Blanche Lincoln; Leg. Dir, Sen. Debbie Stabenow; Prof. Staff, Sen. Agriculture Cmte., Prof. Staff, Sen. Energy & Natural Resources Cmte., Prof. Staff, Sen. Finance Cmte.Q3 2024

Lobbying reports

Filed by
07/08for Q2Holland & Knight$80K
04/17for Q1Holland & Knight$80K
01/15for Q4 2025Holland & Knight$60K
25/10/15for Q3 2025Holland & Knight$50K
25/07/10for Q2 2025Holland & Knight$50K
25/04/15for Q1 2025Holland & Knight$50K
25/01/13for Q4 2024Holland & Knight$50K
24/10/02for Q3 2024Holland & Knight$50K
24/07/08for Q2 2024Holland & Knight$50K
24/04/15for Q1 2024Holland & Knight$30K
24/02/20for Q1 2024Holland & KnightUnder $5,000